Artificial intelligence is rapidly transforming the life sciences—from drug discovery and clinical development to regulatory science and medical decision-making. Much of the current discussion, however, remains narrowly focused on model performance, prediction accuracy, and technical innovation.
In highly regulated life-science environments, performance alone is no longer sufficient.
The Limits of Performance-Driven AI
High-performing AI systems can still fail in real-world settings if their decisions are not explainable, auditable, and institutionally embedded. Regulators, clinicians, and organizations must be able to understand how decisions are made, who remains accountable, and how risks are identified and managed over time.
Without clear governance structures, even technically excellent AI systems may undermine trust, slow adoption, or create regulatory and ethical challenges.